Japan Molecular Cytogenetics Market Size & Outlook

The molecular cytogenetics market in Japan is expected to reach a projected revenue of US$ 387.2 million by 2028. A compound annual growth rate of 12.9% is expected of Japan molecular cytogenetics market from 2021 to 2028.
Revenue, 2020 (US$M)
$146.2
Forecast, 2028 (US$M)
$387.2
CAGR, 2021 - 2028
12.9%
Report Coverage
Japan

Japan molecular cytogenetics market highlights

  • The Japan molecular cytogenetics market generated a revenue of USD 146.2 million in 2020 and is expected to reach USD 387.2 million by 2028.
  • The Japan market is expected to grow at a CAGR of 12.9% from 2021 to 2028.
  • In terms of segment, oncology was the largest revenue generating application in 2020.
  • Oncology is the most lucrative application segment registering the fastest growth during the forecast period.


Molecular cytogenetics market data book summary

Market revenue in 2020USD 146.2 million
Market revenue in 2028USD 387.2 million
Growth rate12.9% (CAGR from 2020 to 2028)
Largest segmentOncology
Fastest growing segmentOncology
Historical data2018 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationGenetic Disorders, Oncology, Personalized Medicine, Other Applications
Key market players worldwideDanaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc


Other key industry trends

  • In terms of revenue, Japan accounted for 8.9% of the global molecular cytogenetics market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Asia Pacific, Japan molecular cytogenetics market is projected to lead the regional market in terms of revenue in 2028.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 298.4 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Cytogenetics Market Scope

Molecular cytogenetics market segmentation & scope
Genetic Disorders
Oncology
Personalized Medicine
Other Applications
Instruments
Consumables
Software & Services
Clinical & Research Laboratories
Hospitals & Path Labs
Academic Research Institutes
Pharmaceutical & Biotech Companies
Others
aCGH
sCGH
FISH
Immunochemistry
Spectral
Virtual
Others

Molecular Cytogenetics Market Companies

Name Profile # Employees HQ Website

Japan molecular cytogenetics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.


Oncology was the largest segment with a revenue share of 39.33% in 2020. Horizon Databook has segmented the Japan molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.


Japan is known for the most advanced technology platforms, like NGS that are available in the field of genomic medicine in the Asian countries. Regulatory guidelines set by Japan are one of the most stringent in the market and thus support development of highly efficient platforms and diagnostics.

Other factors significantly boosting market growth are rapidly ageing population and high incidence of cancers. Government research institutes along with teaching hospitals have partnered with genetic platform manufacturers to co-develop advanced platforms that comply with regulatory standards.

Furthermore, several Japanese organizations initiated various programs to support genomic research in the country, which is expected to drive the market. For instance, in April 2020, the Japan Agency for Medical Research and Development (AMED) introduced Advanced Genome Research and Bioinformatics Study to facilitate medical innovations.

Reasons to subscribe to Japan molecular cytogenetics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan molecular cytogenetics market databook

  • Our clientele includes a mix of molecular cytogenetics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan molecular cytogenetics market , including forecasts for subscribers. This country databook contains high-level insights into Japan molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan molecular cytogenetics market size, by application, 2018-2028 (US$M)

Japan Molecular Cytogenetics Market Outlook Share, 2020 & 2028 (US$M)

Japan molecular cytogenetics market size, by application, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more